Metabolic events during ischaemia are probably important in determining post-ischaemic myocardial recovery. The aim of this study was to assess the effects of the -blocker atenolol and the high energy demand in an ischaemia-reperfusion model free of neurohormonal and vascular factors. We exposed Langendorff-perfused isolated rat hearts to Ž . Ž . low-flow ischaemia 30 min and reflow 20 min . Three groups of hearts were used: control Ž .y 1 Ž . hearts n s 11 , hearts that were perfused with 2.5 g l atenolol n s 9 , and hearts electrically paced during ischaemia to distinguish the effect of heart rate from that of the Ž . drug n s 9 . The hearts were freeze-clamped at the end of reflow to determine high-energy phosphates and their metabolites. During ischaemia, the pressure-rate product was 2.3" 0.2, 5.2" 1.1, and 3.3" 0.3 mmHg 10 3 min in the control, atenolol and paced hearts, respec-Ž . tively. In addition, the ATP turnover rate, calculated from venous lactate , oxygen uptake Ž y1 . Ž y 1 . and flow, was higher in atenolol 11.2" 1.7 mol min and paced 8.1" 0.8 mol min Ž y1 . hearts than in control 6.2" 0.8 mol min . At the end of reflow, the pressure = rate product recovered 75.1" 6.4% of baseline in control¨s 54.1" 9.1 and 48.8" 4.4% in Ž . atenolol and paced hearts P-0.05 . In addition, the tissue content of ATP was higher in Ž y1 . Ž y 1 . the control hearts 15.8" 1.0 mol g than in atenolol 10.5" 2.6 mol g and paced dw dw Ž y1 . 10.9" 1.3 mol g hearts. Thus, by suppressing the protective effects of down-regudw lation, both atenolol and pacing apparently depress myocardial recovery in this model.